- Navigation
- Register My DNA Kit
- Features
- Pricing
- FAQ
- About
- Labs
- Login
- Get started
Interaction | References |
---|---|
[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with fludarabine] results in increased cleavage of CASP3 protein | R |
Interaction | References |
---|---|
[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with fludarabine] results in increased cleavage of CASP8 protein | R |
Interaction | References |
---|---|
Acetylcysteine inhibits the reaction [[fludarabine co-treated with LAQ824] results in increased expression of H2AFX protein] | R |
Interaction | References |
---|---|
Cholecalciferol promotes the reaction [fludarabine results in increased expression of CDKN1A mRNA] | R |
Interaction | References |
---|---|
fludarabine promotes the reaction [resveratrol results in decreased methylation of PTEN promoter] | R |
Interaction | References |
---|---|
fludarabine results in increased expression of and affects the localization of MMP9 protein | R |
Interaction | References |
---|---|
[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with fludarabine] results in increased cleavage of CASP9 protein | R |
Interaction | References |
---|---|
BCL2 affects the reaction [fludarabine results in increased cleavage of and results in increased activity of CASP9 protein] | R |
Interaction | References |
---|---|
[fludarabine co-treated with TNFSF10 protein] results in increased activity of CASP3 protein | R |
Interaction | References |
---|---|
[fludarabine co-treated with Cytarabine co-treated with docetaxel] results in increased expression of TP53 protein | R |